Welcome to LookChem.com Sign In|Join Free

CAS

  • or

141-75-3

Post Buying Request

141-75-3 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

141-75-3 Usage

Chemical Properties

Butyryl chloride is a colorless to light yellow liquid with a strong pungent odor. It undergoes vigorous hydrolysis with water; decomposes in water; soluble in almost aprotic organic solvents. It is used as an intermediate for organic synthesis for the preparation of pharmaceuticals, agrochemicals, dyes, cellulose esters, and peroxide compounds.

Uses

Different sources of media describe the Uses of 141-75-3 differently. You can refer to the following data:
1. Butyryl chloride is used as an intermediate for the synthesis of active pharmaceutical ingredients benzoyl peroxide, t-butyl perbenzoate, and benzophenone. It is also used as an acylation reagent. Further, it is used in the preparation of peroxides such as benzoyl peroxide, benzophenone and t-butyl perbenzoate. In addition to this, it is involved in the preparation of chromones and antiproliferative agents. Butyryl chloride has been used to esterify wood meal dissolved in the ionic liquid, 1-butyl-3-methylimidazolium chloride.
2. Butyryl chloride has been used to esterify wood meal dissolved in the ionic liquid, 1-butyl-3-methylimidazolium chloride.

General Description

A clear colorless liquid with a sharp odor. Slightly denser than water. Flash point near 20°F. Severely irritates skin, eyes, and mucous membranes. Used to make other chemicals.

Air & Water Reactions

Highly flammable. Fumes in air. Decomposes exothermically in water to give corrosive hydrochloric acid.

Reactivity Profile

Butyryl chloride slowly dissolves in water with decomposition and formation of a weakly acidic solution. May react vigorously or explosively if mixed with diisopropyl ether or other ethers in the presence of trace amounts of metal salts [J. Haz. Mat., 1981, 4, 291].

Health Hazard

Extremely destructive to the mucous membranes, upper respiratory tract, eyes, and skin. Inhalation may cause death as a result of spasm, inflammation and edema of the larynx and bronchi, chemical pneumonitis, and pulmonary edema. Symptoms of exposure include burning sensation, coughing, wheezing, laryngitis, shortness of breath, headache, nausea, and vomiting.

Fire Hazard

Special Hazards of Combustion Products: Emits toxic fumes of chlorine gas

Flammability and Explosibility

Flammable

Purification Methods

Check IR to see if there is a significant peak at 3000-3500 cm-1 (br) for OH. If OH is present then reflux with less than one mole equivalent of SOCl2 for 1hour and distil directly. The fraction boiling between 85-100o is then refractionated at atmospheric pressure. Keep all apparatus free from moisture and store the product in sealed glass ampoules under N2. LACHRYMATORY; handle in a good fume hood. [Hefferich & Schaeffer Org Synth Coll Vol I 147 1941, Beilstein 2 IV 803.]

Check Digit Verification of cas no

The CAS Registry Mumber 141-75-3 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 1,4 and 1 respectively; the second part has 2 digits, 7 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 141-75:
(5*1)+(4*4)+(3*1)+(2*7)+(1*5)=43
43 % 10 = 3
So 141-75-3 is a valid CAS Registry Number.
InChI:InChI=1/C4H7ClO/c1-2-3-4(5)6/h2-3H2,1H3

141-75-3 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Alfa Aesar

  • (A17575)  Butyryl chloride, 98%   

  • 141-75-3

  • 50g

  • 210.0CNY

  • Detail
  • Alfa Aesar

  • (A17575)  Butyryl chloride, 98%   

  • 141-75-3

  • 250g

  • 280.0CNY

  • Detail
  • Alfa Aesar

  • (A17575)  Butyryl chloride, 98%   

  • 141-75-3

  • 1000g

  • 952.0CNY

  • Detail
  • Aldrich

  • (236349)  Butyrylchloride  ≥99%

  • 141-75-3

  • 236349-50G

  • 616.59CNY

  • Detail
  • Aldrich

  • (109614)  Butyrylchloride  98%

  • 141-75-3

  • 109614-250G

  • 407.16CNY

  • Detail
  • Aldrich

  • (109614)  Butyrylchloride  98%

  • 141-75-3

  • 109614-1KG

  • 1,254.24CNY

  • Detail

141-75-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 10, 2017

Revision Date: Aug 10, 2017

1.Identification

1.1 GHS Product identifier

Product name Butyryl chloride

1.2 Other means of identification

Product number -
Other names butyric acid chloride

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:141-75-3 SDS

141-75-3Synthetic route

butyric acid
107-92-6

butyric acid

butyryl chloride
141-75-3

butyryl chloride

Conditions
ConditionsYield
With thionyl chloride; N,N-dimethyl-formamide In toluene at 100 - 102℃; for 9h;92%
With thionyl chloride In N,N-dimethyl-formamide Reflux;90.9%
With thionyl chloride for 0.5h; Heating;86%
butyric acid
107-92-6

butyric acid

A

butanoic acid anhydride
106-31-0

butanoic acid anhydride

B

butyryl chloride
141-75-3

butyryl chloride

Conditions
ConditionsYield
With phosphorus trichloride at 40 - 50℃; 4-5h;A n/a
B 67%
With phosphorus trichloride at 40 - 50℃; 4-5h;A 10.54%
B 49.3%
trimethylsilyl butyrate
16844-99-8

trimethylsilyl butyrate

chlorosulfonate de trimethylsilyle
4353-77-9

chlorosulfonate de trimethylsilyle

A

2-(Trimethylsiloxysulfonyl)-butansaeure-trimethylsilylester
89056-03-1

2-(Trimethylsiloxysulfonyl)-butansaeure-trimethylsilylester

B

butyryl chloride
141-75-3

butyryl chloride

Conditions
ConditionsYield
In 1,2-dichloro-ethane for 12h; Heating;A 62%
B n/a
acryloyl chloride
814-68-6

acryloyl chloride

methylhydridomercury(II)
51176-12-6

methylhydridomercury(II)

butyryl chloride
141-75-3

butyryl chloride

Conditions
ConditionsYield
56%
benzoyl chloride
98-88-4

benzoyl chloride

butyric acid
107-92-6

butyric acid

butyryl chloride
141-75-3

butyryl chloride

Conditions
ConditionsYield
durch Destillation;
tetrachloromethane
56-23-5

tetrachloromethane

butyraldehyde
123-72-8

butyraldehyde

A

hexachloroethane
67-72-1

hexachloroethane

B

2-ethylhexenal
645-62-5

2-ethylhexenal

C

butyryl chloride
141-75-3

butyryl chloride

Conditions
ConditionsYield
bei der Einwirkung von γ-Strahlen;
Benzotrichlorid
98-07-7

Benzotrichlorid

butyric acid
107-92-6

butyric acid

butyryl chloride
141-75-3

butyryl chloride

Conditions
ConditionsYield
With zinc(II) chloride at 70 - 80℃;
Phthaloyl dichloride
88-95-9

Phthaloyl dichloride

butyric acid
107-92-6

butyric acid

butyryl chloride
141-75-3

butyryl chloride

Conditions
ConditionsYield
durch Destillation;
1,1-dichloroethyl ethyl ether
50966-31-9

1,1-dichloroethyl ethyl ether

butyric acid
107-92-6

butyric acid

butyryl chloride
141-75-3

butyryl chloride

isobutyryl chloride
79-30-1

isobutyryl chloride

butyryl chloride
141-75-3

butyryl chloride

Conditions
ConditionsYield
aluminium trichloride; Pd(Ph3)3(Cl)(COCH3)+AlCl3 In chloroform-d1 at 50℃; for 168h; Product distribution; variation of calyst;
benzoyl chloride
98-88-4

benzoyl chloride

butyric acid
107-92-6

butyric acid

A

benzoic acid anhydride
93-97-0

benzoic acid anhydride

B

butyryl chloride
141-75-3

butyryl chloride

Conditions
ConditionsYield
With pyridine N-oxide In dichloromethane; water Mechanism; var. pH, temp., var. concentration PNO;
butyric acid (2 mol )

butyric acid (2 mol )

butyryl chloride
141-75-3

butyryl chloride

Conditions
ConditionsYield
With phosphorus trichloride Erhitzen im kochenden Wasserbade und Abdestillieren des gebildeten Butyrylchlorids aus dem Oelbade;
With phosphorus trichloride Erhitzen im kochenden Wasserbade und Abdestillieren des gebildeten Butyrylchlorids im Vakuum;
butyric acid (96 parts )

butyric acid (96 parts )

butyryl chloride
141-75-3

butyryl chloride

Conditions
ConditionsYield
With phosphorus trichloride destillieren;
<1-chloro-ethyl>-butyrate

<1-chloro-ethyl>-butyrate

A

acetaldehyde
75-07-0

acetaldehyde

B

butyryl chloride
141-75-3

butyryl chloride

Conditions
ConditionsYield
With zinc(II) chloride
butyric acid 1-chloroethyl ester
80195-91-1

butyric acid 1-chloroethyl ester

ZnCl2

ZnCl2

A

acetaldehyde
75-07-0

acetaldehyde

B

butyryl chloride
141-75-3

butyryl chloride

C

paracetaldehyde
123-63-7

paracetaldehyde

butyraldehyde
123-72-8

butyraldehyde

butyryl chloride
141-75-3

butyryl chloride

Conditions
ConditionsYield
With trichloroisocyanuric acid In dichloromethane at 20℃; for 120h; Inert atmosphere;
oxalyl dichloride
79-37-8

oxalyl dichloride

butyric acid
107-92-6

butyric acid

butyryl chloride
141-75-3

butyryl chloride

Conditions
ConditionsYield
In dichloromethane at 20℃; for 3h; Inert atmosphere;
phenethylamine
64-04-0

phenethylamine

butyryl chloride
141-75-3

butyryl chloride

N-(2-phenylethyl)butanamide
6283-13-2

N-(2-phenylethyl)butanamide

Conditions
ConditionsYield
With triethylamine In dichloromethane at 0 - 30℃; for 12h;100%
In dichloromethane at 20℃; for 1h; Inert atmosphere;100%
With pyridine
In benzene for 1h; Heating;
With triethylamine In dichloromethane at 0 - 20℃;
4-nitro-aniline
100-01-6

4-nitro-aniline

butyryl chloride
141-75-3

butyryl chloride

N-(4'-nitrophenyl)butyramide
54191-12-7

N-(4'-nitrophenyl)butyramide

Conditions
ConditionsYield
With NMM In dichloromethane100%
With triethylamine In dichloromethane at 20℃;71%
With sodium hydroxide; acetone
diethylamine
109-89-7

diethylamine

butyryl chloride
141-75-3

butyryl chloride

N,N-diethyl-butyramide
1114-76-7

N,N-diethyl-butyramide

Conditions
ConditionsYield
With triethylamine In dichloromethane at 0 - 20℃;100%
With benzene
With diethyl ether
In benzene
With sodium carbonate In benzene at 0 - 5℃;
butyryl chloride
141-75-3

butyryl chloride

4-bromo-aniline
106-40-1

4-bromo-aniline

N-(4-bromophenyl)butanamide
119199-11-0

N-(4-bromophenyl)butanamide

Conditions
ConditionsYield
With triethylamine In dichloromethane at 5 - 20℃;100%
With triethylamine In chloroform at 20℃; for 0.0222222h; Flow reactor;82%
butyryl chloride
141-75-3

butyryl chloride

β-naphthol
135-19-3

β-naphthol

β-naphthyl butyrate
5856-33-7

β-naphthyl butyrate

Conditions
ConditionsYield
With triethylamine In dichloromethane at 0 - 20℃;100%
CYANAMID
420-04-2

CYANAMID

butyryl chloride
141-75-3

butyryl chloride

n-butyrylcyanamide
5634-65-1

n-butyrylcyanamide

Conditions
ConditionsYield
With sodium hydroxide In acetone100%
With triethylamine In benzene
butyryl chloride
141-75-3

butyryl chloride

Propargylamine
2450-71-7

Propargylamine

N-(prop-2-yn-1-yl)butyramide
2978-28-1

N-(prop-2-yn-1-yl)butyramide

Conditions
ConditionsYield
With N-ethyl-N,N-diisopropylamine In dichloromethane at 0 - 20℃;100%
With pyridine In diethyl ether97%
With triethylamine In dichloromethane at 0 - 20℃; for 3h; Huisgen Cycloaddition;82%
1,8-dihydroxy-9,10-anthracenedione
117-10-2

1,8-dihydroxy-9,10-anthracenedione

butyryl chloride
141-75-3

butyryl chloride

Butyric acid 8-butyryloxy-9,10-dioxo-9,10-dihydro-anthracen-1-yl ester

Butyric acid 8-butyryloxy-9,10-dioxo-9,10-dihydro-anthracen-1-yl ester

Conditions
ConditionsYield
In pyridine for 3h; Ambient temperature;100%
butyryl chloride
141-75-3

butyryl chloride

(R)-N-(1S,2R)-<3-<2-<<(1,1-dimethylethyl)amino>carbonyl>phenyl>-2-hydroxy-1-(phenylmethyl)propyl>-2-amino-4-oxo-4-(benzyloxy)butanamide
159142-00-4

(R)-N-(1S,2R)-<3-<2-<<(1,1-dimethylethyl)amino>carbonyl>phenyl>-2-hydroxy-1-(phenylmethyl)propyl>-2-amino-4-oxo-4-(benzyloxy)butanamide

(R)-N-(1S,2R)-<3-<2-<<(1,1-dimethylethyl)amino>carbonyl>phenyl>-2-hydroxy-1-(phenylmethyl)propyl>-2-<(n-propylcarbonyl)amino>-4-oxo-4-(benzyloxy)butanamide

(R)-N-(1S,2R)-<3-<2-<<(1,1-dimethylethyl)amino>carbonyl>phenyl>-2-hydroxy-1-(phenylmethyl)propyl>-2-<(n-propylcarbonyl)amino>-4-oxo-4-(benzyloxy)butanamide

Conditions
ConditionsYield
With triethylamine In dichloromethane for 0.25h; Ambient temperature;100%
1,2,3,4-tetrahydroisoquinoline
91-21-4

1,2,3,4-tetrahydroisoquinoline

butyryl chloride
141-75-3

butyryl chloride

N-butyryl-1,2,3,4-tetrahydroisoquinoline

N-butyryl-1,2,3,4-tetrahydroisoquinoline

Conditions
ConditionsYield
With triethylamine In dichloromethane100%
(R)-4-(phenylmethyl)-2-oxazolidinone
40217-17-2, 90719-32-7, 120574-96-1, 102029-44-7

(R)-4-(phenylmethyl)-2-oxazolidinone

butyryl chloride
141-75-3

butyryl chloride

(R)-3-(1-butyryl)-4-benzyloxazolidine-2-one
111292-87-6, 112459-79-7, 143097-11-4

(R)-3-(1-butyryl)-4-benzyloxazolidine-2-one

Conditions
ConditionsYield
Stage #1: (R)-4-(phenylmethyl)-2-oxazolidinone With n-butyllithium In tetrahydrofuran; hexane at -78℃; for 0.5h; Inert atmosphere;
Stage #2: butyryl chloride In tetrahydrofuran; hexane at 20℃; Inert atmosphere;
100%
Stage #1: (R)-4-(phenylmethyl)-2-oxazolidinone With n-butyllithium In tetrahydrofuran at -78℃; for 0.5h; Inert atmosphere;
Stage #2: butyryl chloride In tetrahydrofuran at -78 - 20℃; for 0.5h; Inert atmosphere;
100%
Stage #1: (R)-4-(phenylmethyl)-2-oxazolidinone With n-butyllithium In tetrahydrofuran at -78℃; for 1h; Inert atmosphere;
Stage #2: butyryl chloride In tetrahydrofuran at -78 - 20℃; Inert atmosphere;
99%
2-Phenoxyethanol
122-99-6

2-Phenoxyethanol

butyryl chloride
141-75-3

butyryl chloride

2-phenoxyethyl butyrate
23511-70-8

2-phenoxyethyl butyrate

Conditions
ConditionsYield
With pyridine100%
2-mercaptothiazoline
96-53-7

2-mercaptothiazoline

butyryl chloride
141-75-3

butyryl chloride

1-(2-thioxothiazolidin-3-yl)butan-1-one
75594-82-0

1-(2-thioxothiazolidin-3-yl)butan-1-one

Conditions
ConditionsYield
With triethylamine In dichloromethane at 0 - 20℃; for 2h;100%
butyryl chloride
141-75-3

butyryl chloride

4-hydroxy-2H-1,4-benzoxazin-3-one
771-26-6

4-hydroxy-2H-1,4-benzoxazin-3-one

4-butanoyloxy-(2H)-1,4-benzoxazin-3(4H)-one

4-butanoyloxy-(2H)-1,4-benzoxazin-3(4H)-one

Conditions
ConditionsYield
With pyridine at 20℃; for 12h;100%
With pyridine for 12h;99%
butyryl chloride
141-75-3

butyryl chloride

4-hydroxy-6-methoxy-(2H)-1,4-benzoxazin-3(4H)-one
69884-06-6

4-hydroxy-6-methoxy-(2H)-1,4-benzoxazin-3(4H)-one

4-butanoyloxy-6-methoxy-(2H)-1,4-benzoxazin-3(4H)-one

4-butanoyloxy-6-methoxy-(2H)-1,4-benzoxazin-3(4H)-one

Conditions
ConditionsYield
With pyridine at 20℃; for 12h;100%
butyryl chloride
141-75-3

butyryl chloride

ethyl (triphenylphosphoranylidene)acetate
1099-45-2

ethyl (triphenylphosphoranylidene)acetate

ethyl hexa-2,3-dienoate
131431-64-6, 113644-17-0

ethyl hexa-2,3-dienoate

Conditions
ConditionsYield
With triethylamine In dichloromethane at 20℃;100%
Stage #1: ethyl (triphenylphosphoranylidene)acetate With triethylamine In dichloromethane for 0.166667h;
Stage #2: butyryl chloride In dichloromethane at -20 - 0℃; for 0.166667h;
97%
tert-butyl 2-[1-(3-aminophenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-yl]hydrazinecarboxylate
650628-27-6

tert-butyl 2-[1-(3-aminophenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-yl]hydrazinecarboxylate

butyryl chloride
141-75-3

butyryl chloride

N-[3-(4-tert-butylhydrazino-1H-pyrazolo[3,4-d]pyrimidin-1-yl)phenyl]butanamide

N-[3-(4-tert-butylhydrazino-1H-pyrazolo[3,4-d]pyrimidin-1-yl)phenyl]butanamide

Conditions
ConditionsYield
With triethylamine In tetrahydrofuran at 20℃; for 1h;100%
Ro 0329774
663198-02-5

Ro 0329774

butyryl chloride
141-75-3

butyryl chloride

N-[3-(4-methoxyphenyl)-2-oxo-1-phenyl(1,3,4-trihydropyrimidino[4,5-d]pyrimidin-7-yl)]-N-phenylbutanamide

N-[3-(4-methoxyphenyl)-2-oxo-1-phenyl(1,3,4-trihydropyrimidino[4,5-d]pyrimidin-7-yl)]-N-phenylbutanamide

Conditions
ConditionsYield
With N-ethyl-N,N-diisopropylamine In dichloromethane at 20℃; for 4h;100%
3-bromo-5-methoxyaminobenzene
16618-68-1

3-bromo-5-methoxyaminobenzene

butyryl chloride
141-75-3

butyryl chloride

C11H14BrNO2
1056894-18-8

C11H14BrNO2

Conditions
ConditionsYield
With triethylamine In dichloromethane at 5 - 20℃; for 1h;100%
4-((1R,2R)-1-(5-(4-aminophenyl)-1,3,4-oxadiazol-2-yl)-2-(tert-butyldimethylsilyloxy)propylamino)-2-chloro-3-methylbenzonitrile
1182369-02-3

4-((1R,2R)-1-(5-(4-aminophenyl)-1,3,4-oxadiazol-2-yl)-2-(tert-butyldimethylsilyloxy)propylamino)-2-chloro-3-methylbenzonitrile

butyryl chloride
141-75-3

butyryl chloride

N-(4-(5-((1R,2R)-2-(tert-butyldimethylsilyloxy)-1-(3-chloro-4-cyano-2-methylphenylamino)propyl)-1,3,4-oxadiazol-2-yl)phenyl)butyramide
1182369-07-8

N-(4-(5-((1R,2R)-2-(tert-butyldimethylsilyloxy)-1-(3-chloro-4-cyano-2-methylphenylamino)propyl)-1,3,4-oxadiazol-2-yl)phenyl)butyramide

Conditions
ConditionsYield
With pyridine In dichloromethane at 20℃; for 90h;100%
4-[(tert-butyldimethylsilyl)oxy]aniline
111359-74-1

4-[(tert-butyldimethylsilyl)oxy]aniline

butyryl chloride
141-75-3

butyryl chloride

4'-tert-butyldimethylsilyloxybutyrylanilide
1318981-71-3

4'-tert-butyldimethylsilyloxybutyrylanilide

Conditions
ConditionsYield
With triethylamine In dichloromethane at 20℃; for 15h;100%
With triethylamine In dichloromethane
4-hydroxy-benzaldehyde
123-08-0

4-hydroxy-benzaldehyde

butyryl chloride
141-75-3

butyryl chloride

4-ethylacetoxy benzaldehyde
50262-49-2

4-ethylacetoxy benzaldehyde

Conditions
ConditionsYield
With triethylamine In tetrahydrofuran at 0 - 20℃; Inert atmosphere;100%
2-nitro-6-(pyrrolidin-3-ylmethoxy)benzonitrile hydrochloride
1093205-46-9

2-nitro-6-(pyrrolidin-3-ylmethoxy)benzonitrile hydrochloride

butyryl chloride
141-75-3

butyryl chloride

2-nitro-6-((1-butyrylpyrrolidin-3-yl)methoxy)benzonitrile
1093205-49-2

2-nitro-6-((1-butyrylpyrrolidin-3-yl)methoxy)benzonitrile

Conditions
ConditionsYield
100%
m-Anisidine
536-90-3

m-Anisidine

butyryl chloride
141-75-3

butyryl chloride

N-(3-methoxyphenyl)butanamide
132118-40-2

N-(3-methoxyphenyl)butanamide

Conditions
ConditionsYield
With pyridine In dichloromethane at 20℃; for 18h; Inert atmosphere;100%
With dmap; triethylamine In dichloromethane at 0 - 20℃; for 18h; Inert atmosphere;82%
In dichloromethane
Stage #1: m-Anisidine With triethylamine In tetrahydrofuran at 0℃; for 0.333333h;
Stage #2: butyryl chloride In tetrahydrofuran at 20℃; for 13h;
Stage #1: m-Anisidine With triethylamine In tetrahydrofuran at 25℃; for 0.166667h;
Stage #2: butyryl chloride In tetrahydrofuran at 25℃; for 3h; Sealed tube;
butyryl chloride
141-75-3

butyryl chloride

3-Iodoaniline
626-01-7

3-Iodoaniline

N-(3-iodophenyl)butyramide
1011615-39-6

N-(3-iodophenyl)butyramide

Conditions
ConditionsYield
With pyridine In dichloromethane at 20℃; for 18h; Inert atmosphere;100%
ethyl benzimidate hydrochloride
5333-86-8

ethyl benzimidate hydrochloride

butyryl chloride
141-75-3

butyryl chloride

N-butyryl-benzimidic acid ethyl ester
33243-87-7

N-butyryl-benzimidic acid ethyl ester

Conditions
ConditionsYield
Stage #1: ethyl benzimidate hydrochloride With triethylamine In toluene at 20℃; for 0.166667h;
Stage #2: butyryl chloride In toluene at 20℃; for 24h;
100%
ethyl naphthalene-2-carboximidate hydrochloride
4278-14-2

ethyl naphthalene-2-carboximidate hydrochloride

butyryl chloride
141-75-3

butyryl chloride

C17H19NO2
1415127-32-0

C17H19NO2

Conditions
ConditionsYield
Stage #1: ethyl naphthalene-2-carboximidate hydrochloride With triethylamine In toluene at 20℃; for 0.166667h;
Stage #2: butyryl chloride In toluene at 20℃; for 41.5h;
100%
Stage #1: ethyl naphthalene-2-carboximidate hydrochloride With triethylamine In toluene at 20℃; for 0.166667h;
Stage #2: butyryl chloride In toluene at 20℃; for 41.5h;
100%
butyryl chloride
141-75-3

butyryl chloride

3-benzyl-4-ethyl-7-hydroxy-2H-chromen-2-one

3-benzyl-4-ethyl-7-hydroxy-2H-chromen-2-one

3-benzyl-4-ethyl-2-oxo-2H-chromen-7-yl butyrate
1428238-84-9

3-benzyl-4-ethyl-2-oxo-2H-chromen-7-yl butyrate

Conditions
ConditionsYield
Stage #1: 3-benzyl-4-ethyl-7-hydroxy-2H-chromen-2-one With sodium hydride In N,N-dimethyl-formamide at 20℃; for 0.5h; Inert atmosphere;
Stage #2: butyryl chloride In N,N-dimethyl-formamide at 20℃; for 1h; Inert atmosphere;
100%
C23H23N7O4S
1429324-16-2

C23H23N7O4S

butyryl chloride
141-75-3

butyryl chloride

C27H29N7O5S
1429324-21-9

C27H29N7O5S

Conditions
ConditionsYield
With triethylamine In dichloromethane for 1h; Inert atmosphere;100%
piperidine
110-89-4

piperidine

butyryl chloride
141-75-3

butyryl chloride

1-(piperidin-1-yl)butan-1-one
4637-70-1

1-(piperidin-1-yl)butan-1-one

Conditions
ConditionsYield
With triethylamine In dichloromethane at 0 - 20℃;100%
With triethylamine In chloroform at 20℃; for 0.0222222h; Reagent/catalyst; Flow reactor;99.9%
With triethylamine In dichloromethane at 0 - 20℃; for 14h; Inert atmosphere;99%

141-75-3Related news

A conformational study of Butyryl chloride (cas 141-75-3) using chirped pulse Fourier transform microwave spectroscopy and quantum chemical calculations09/29/2019

The pure rotational spectrum of butyryl chloride has been recorded between 8 and 16GHz using a chirped pulse, Fourier transform microwave spectrometer. The transitions recorded were assigned to two different conformers which have previously been designated syn-gauche and syn-anti. Quantum chemic...detailed

141-75-3Relevant articles and documents

Stereoselective, solid phase-based synthesis of trans 3-alkyl-substituted β-lactams as analogues of cholesterol absorption inhibitors

Delpiccolo, Carina M.L.,Testero, Sebastián A.,Leyes, Federico N.,Boggián, Dora B.,Camacho, Cristián M.,Mata, Ernesto G.

, p. 10780 - 10786 (2012)

A straightforward solid phase-based strategy for the rapid generation of two small libraries of trans 3-alkyl-substituted β-lactams is described. For the glycine-derived library, a controlled excess of nonactivated acid chlorides was used to prevent oxazinone formation. The second library involved the attachment of Fmoc-protected p-aminophenol to Wang resin for the preparation of structurally-closed analogues of known cholesterol absorption inhibitors. This strategy allowed us to introduce diversity in the three variable positions of the β-lactam ring.

Novel inhibitors of tyrosinase produced by the 4-substitution of TCT (П)

Liu, Jing,Li, Mengrong,Yu, Yanying,Cao, Shuwen

, p. 1096 - 1106 (2017)

Novel Tyrosinase Inhibitors of 4-functionalized Thiophene-2-carbaldehyde thiosemicarbazone (TCT) derivatives (1–8) had been synthesized and Spectrofluorimetry, 1H and 13C NMR titration and Molecular docking had been used to investigate their inhibitory activities and mechanisms on tyrosinase. The results showed that the inter-molecular interactions or hydrogen bond formation by increasing length of carbon chain or introducing benzene ring to the 4-functionalized ester group promoted or stabilized formation of complexes between modifier and tyrosinase, and enhanced the inhibitory activity of modifiers. The inhibitory activity of 4-benzoy methoxy-TCT was much stronger than that of any other synthesized tested modifiers, which was well explained by molecular docking and further verified by spectrofluorimetry and NMR titration by assuming that there existed an inter-molecular interaction besides formation of hydrogen bonds between the amino acid residues ASN260, GLU256, HIS85 of enzyme and the modifier.We concluded that 4-benzoy methoxy substitution of TCT was a good route obtaining novel tyrosinase inhibitors and deserved further studies.

Carboxamides as N-Alkylating Reagents of Secondary Amines in Indium-Catalyzed Reductive Amination with a Hydrosilane

Ogiwara, Yohei,Shimoda, Wataru,Ide, Keisuke,Nakajima, Takumi,Sakai, Norio

, p. 2866 - 2870 (2017)

A method for the catalytic reductive N-alkylation of amines by using secondary amides as the alkyl source was developed. A versatile type of carboxamide functioned as an N-alkylation reagent in the presence of an indium(III) catalyst and a hydrosilane to provide alkylated tertiary amines efficiently. This amide-based catalytic N-alkylation strategy is considered to be a highly useful protocol to access unsymmetrical tertiary amines.

Synthesis and bioactivities of diamide derivatives containing a phenazine-1-carboxamide scaffold

Zhu, Xiang,Zhang, Min,Yu, Linhua,Xu, Zhihong,Yang, Dan,Du, Xiaoying,Wu, Qinglai,Li, Junkai

, p. 2453 - 2460 (2019)

Taking natural product phenazine-1-carboxamide (PCN) as a lead compound, a series of novel phenazine-1-carboxylic acid diamide derivatives were designed and synthesised. Their structures were confirmed by 1H-NMR and HRMS. The bioassays showed that some of the target compounds exhibited promising in vitro fungicidal activities, and exhibited excellent and selective herbicidal activities. Particularly, compounds c, h, o and s displayed root length inhibition activities against barnyard grass with the rate of more than 80%. Compound c exhibited the best activity among all the target compounds against barnyard grass stalk length with the IC50 value of 0.158?mmol/L, and compound o exhibited the best and wide spectrum inhibition against barnyard grass root length and rape in both root length and stalk length herbicidal activities with its IC50 values of 0.067, 0.048 and 0.059?mmol/L respectively. The analysis of preliminary Structure-Activity Relationships provides the theoretical basis for further design of phenazine-1-carboxylic acid.

Computational discovery, structural optimization and biological evaluation of novel inhibitors targeting transient receptor potential vanilloid type 3 (TRPV3)

Zhang, Fang,Lin, Yiyu,Min, Wenjian,Hou, Yi,Yuan, Kai,Wang, Jin,Yang, Peng

, (2021)

Transient receptor potential vanilloid type 3 (TRPV3) is a Ca2+ permeable nonselective cation channel and expressed abundantly in skin keratinocytes. TRPV3 emerges as an attractive target for treatment of pruritic, inflammatory, pain and skin-related diseases. However, only a few reports of TRPV3 inhibitors exist at present besides some patents. Therefore, TRPV3 research has always been fraught with challenges. Through a combination of virtual screening and biological evaluation, compound P1 (10 μM) was identified as a top hit with 34.5% inhibitory effect on 2-APB (1 mM)-evoked currents of mTRPV3-WT. Further structural optimization provided the inhibitor PC5 with the best activity (IC50 = 2.63 ± 0.28 μM), and point mutation assays indicated that amino acids V629 and F633 are crucial for the binding of PC5 and TRPV3. In summary, these newly discovered inhibitors could serve as promising lead compounds for the development of TRPV3 inhibitors in the future.

Lead derivatization of ethyl 6-bromo-2-((dimethylamino)methyl)-5-hydroxy-1-phenyl-1H-indole-3-carboxylate and 5-bromo-2-(thiophene-2-carboxamido) benzoic acid as FabG inhibitors targeting ESKAPE pathogens

Varakala, Saiprasad Dasugari,Reshma, Rudraraju Srilakshmi,Schnell, Robert,Dharmarajan, Sriram

, (2021/11/26)

Our previous studies on FabG have identified two compounds 5-bromo-2-(thiophene-2-carboxamido) benzoic acid (A) and ethyl 6-bromo-2-((dimethylamino)methyl)-5-hydroxy-1-phenyl-1H-indole-3-carboxylate(B) as best hits with allosteric mode of inhibition. FabG is an integral part of bacterial fatty acid biosynthetic system FAS II shown to be an essential gene in most ESKAPE Pathogens. The current work is focussed on lead expansion of these two hit molecules which ended up with forty-three analogues (twenty-nine analogues from lead compound A and fourteen compounds from lead compound B). The enzyme inhibition studies revealed that compound 15 (effective against EcFabG, AbFabG, StFabG, MtFabG1) and 19 (inhibiting EcFabG and StFabG) had potency of broad-spectrum inhibition on FabG panel.

Synthesis, characterization, antimicrobial, antioxidant and computational evaluation of N-acyl-morpholine-4-carbothioamides

Aziz, Hamid,Saeed, Aamer,Khan, Muhammad Aslam,Afridi, Shakeeb,Jabeen, Farukh

, p. 763 - 776 (2020/03/04)

Abstract: The present research paper reports the convenient synthesis, successful characterization, in vitro antibacterial, antifungal, antioxidant potency and biocompatibility of N-acyl-morpholine-4-carbothioamides (5a–5j). The biocompatible derivatives were found to be highly active against the tested bacterial and fungal strains. Moreover, some of the screened N-acyl-morpholine-4-carbothioamides exhibited excellent antioxidant potential. Docking simulation provided additional information about possibilities of their inhibitory potential against RNA. It has been predicted by in silico investigation of the binding pattern that compounds 5a and 5j can serve as the potential surrogate for design of novel and potent antibacterial agents. The results for the in vitro bioassays were promising with the identification of compounds 5a and 5j as the lead and selective candidate for RNA inhibition. Results of the docking computations further ascertained the inhibitory potential of compound 5a. Based on the in silico studies, it can be suggested that compounds 5a and 5j can serve as a structural model for the design of antibacterial agents with better inhibitory potential. Graphic abstract: Binding mode of compound 5j inside the active site of RNA in 3D space. 5j displayed highest antibacterial potential than the reference drug ampicillin with ZOI 10.50?mm against Staphylococcus aureus. 5j also displayed highest antifungal potential than the reference drug amphotericin B with ZOI 18.20?mm against Fusarium solani.[Figure not available: see fulltext.].

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 141-75-3